STATEMENTS OF CASH FLOW	7 Months Ended
	Dec. 31, 2022 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (123,960)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation expense	93,780
Unrealized gain on investments held in Trust Account	(13,351)
Changes in operating assets and liabilities:
Prepaid expenses	(124,065)
Non-current prepaid expenses	(19,716)
Accounts payable and accrued expenses	34,842
Net Cash Used in Operating Activities	(152,470)
Cash Flows from Investing Activities:
Purchase of investments held in Trust Account	(70,207,500)
Net Cash Used in Investing Activities	(70,207,500)
Cash Flows from Financing Activities:
Proceeds from sale of public units through public offerings, net of underwriters' discount	67,620,000
Proceeds from sale of private placement units	3,857,500
Proceeds from issuance of promissory note to related party	389,200
Repayment of promissory note to related party	(389,200)
Payment of offering costs	(556,124)
Net Cash Provided by Financing Activities	70,921,376
Net Change in Cash	561,406
Cash, beginning of period	0
Cash, end of period	561,406
Supplemental Disclosure of Cash Flow Information:
Offering costs paid by Sponsor in exchange for issuance of ordinary shares	25,000
Deferred underwriting commission charged to additional paid in capital	2,415,000
Issuance of representative shares	1,046,000
Initial accretion of carrying value for public shares to redemption value	(14,613,545)
Subsequent accretion of carrying value for public shares to redemption value	$ (13,351)